These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


85 related items for PubMed ID: 3560102

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
    Cham BE, Bochner F, Imhoff DM, Byrne G, Gunsberg M.
    J Pharmacol Exp Ther; 1982 Mar; 220(3):648-53. PubMed ID: 7062274
    [Abstract] [Full Text] [Related]

  • 24. Acute effects of acetylsalicylic acid on renal and hepatic function in normal humans.
    Husted SE, Nielsen HK, Petersen T, Mogensen CE, Geday E.
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):141-4. PubMed ID: 3888856
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Combined embryotoxic action of toluene, a widely used industrial chemical, and acetylsalicylic acid (aspirin).
    Ungváry G, Tátrai E, Lõrincz M, Barcza G.
    Teratology; 1983 Apr; 27(2):261-9. PubMed ID: 6867949
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
    Kölle EU, Vollmer KO.
    Br J Clin Pharmacol; 1986 Apr; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Protein binding of aspirin and salicylate measured by in vivo ultrafiltration.
    Ghahramani P, Rowland-Yeo K, Yeo WW, Jackson PR, Ramsay LE.
    Clin Pharmacol Ther; 1998 Mar; 63(3):285-95. PubMed ID: 9542472
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency.
    Brooks PM, McCredie M, Prowse M, Podgorski M, Forrest M, Munro I, Boutagy J, Pei-Ling L.
    Pharmatherapeutica; 1986 Mar; 4(10):665-72. PubMed ID: 3602018
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A comparison of isoxicam pharmacokinetics in young and elderly subjects.
    George CF, Renwick AG, Darragh AS, Hosie J, Blake D, van Marle W, Frank GJ.
    Br J Clin Pharmacol; 1986 Mar; 22 Suppl 2(Suppl 2):129S-134S. PubMed ID: 3620272
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
    Ballerini R, Casini A, Chinol M, Mannucci C, Melani F, Ungar F.
    Drugs Exp Clin Res; 1985 Mar; 11(8):517-21. PubMed ID: 3841790
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of antacids on salicylate kinetics.
    Shastri RA.
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):480-4. PubMed ID: 4055159
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of impairment of renal function on the accumulation and disposition of isoxicam.
    Bury RW, Whitworth JA, Saines D, Kincaid-Smith P, Moulds RF.
    Eur J Clin Pharmacol; 1985 Sep; 28(5):585-8. PubMed ID: 4043201
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.